Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations - PubMed (original) (raw)

Review

Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations

D A Wirtzfeld et al. Ann Surg Oncol. 2001 May.

Abstract

Hamartomatous polyposis syndromes are characterized by an overgrowth of cells or tissues native to the area in which they normally occur. Juvenile polyposis syndrome (JPS) results from germ-line mutations in the SMAD-4 gene (18q21.1) that encodes for an enzyme involved in transforming growth factor beta(TGF-beta) signal transduction. The increased neoplastic risk may result from SMAD-4 mutations in the stromal component, which stimulate epithelial dysplasia and progression to invasive malignancy. Peutz-Jeghers syndrome (PJS) is associated with germ-line mutations in the LKB1 gene (19p13.3) that encodes a multifunctional serine-threonine kinase. These mutations occur in the epithelial component, suggesting a direct tumor suppressor effect. Patients are at an increased risk of intestinal and extraintestinal malignancies, including breast, pancreatic, ovarian, testicular, and cervical cancer. Cowden's disease is associated with germ-line mutations in the PTEN gene (10q22-23) and an increased risk of breast and thyroid malignancies. Ruvalcaba-Myhre-Smith syndrome is less common; controversy suggests that it may represent a variant of Cowden's disease.

Conclusions: Genetic alterations underlying hamartomatous polyposis syndromes are diverse. Carcinogenesis may result from either germ-line mutations in the stroma (JPS) or as a direct result of functional deletion of tumor suppressor genes (PJS). Diagnosis depends on clinical presentation and patterns of inheritance within families. Suggested surveillance guidelines for the proband and first-degree relatives are outlined.

PubMed Disclaimer

Cited by

Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood.
Manfredi M. Manfredi M. Gastroenterol Hepatol (N Y). 2010 Mar;6(3):185-96. Gastroenterol Hepatol (N Y). 2010. PMID: 20567567 Free PMC article.
PTEN-deficient intestinal stem cells initiate intestinal polyposis.
He XC, Yin T, Grindley JC, Tian Q, Sato T, Tao WA, Dirisina R, Porter-Westpfahl KS, Hembree M, Johnson T, Wiedemann LM, Barrett TA, Hood L, Wu H, Li L. He XC, et al. Nat Genet. 2007 Feb;39(2):189-98. doi: 10.1038/ng1928. Epub 2007 Jan 21. Nat Genet. 2007. PMID: 17237784 Free PMC article.
Peutz-Jeghers syndrome: diagnostic and therapeutic approach.
Kopacova M, Tacheci I, Rejchrt S, Bures J. Kopacova M, et al. World J Gastroenterol. 2009 Nov 21;15(43):5397-408. doi: 10.3748/wjg.15.5397. World J Gastroenterol. 2009. PMID: 19916169 Free PMC article. Review.
Clinical utility of array comparative genomic hybridization: uncovering tumor susceptibility in individuals with developmental delay.
Adam MP, Justice AN, Schelley S, Kwan A, Hudgins L, Martin CL. Adam MP, et al. J Pediatr. 2009 Jan;154(1):143-6. doi: 10.1016/j.jpeds.2008.07.045. J Pediatr. 2009. PMID: 19187739 Free PMC article.
Rectal carcinoma in a young female patient with Peutz-Jeghers syndrome: a case report.
Tsai HL, Lin CH, Cheng YL, Huang CW, Wang JY. Tsai HL, et al. Med Princ Pract. 2014;23(1):89-91. doi: 10.1159/000351885. Epub 2013 Sep 3. Med Princ Pract. 2014. PMID: 24008657 Free PMC article.

Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations - PubMed (original) (raw)